358 related articles for article (PubMed ID: 26628296)
1. Serum microRNAs as potential noninvasive biomarkers for glioma.
Yu X; Li Z
Tumour Biol; 2016 Feb; 37(2):1407-10. PubMed ID: 26628296
[TBL] [Abstract][Full Text] [Related]
2. Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma.
Tang Y; Zhao S; Wang J; Li D; Ren Q; Tang Y
Neurol Sci; 2017 Jun; 38(6):1087-1092. PubMed ID: 28367610
[TBL] [Abstract][Full Text] [Related]
3. Circulating biomarkers for high-grade glioma.
Loo HK; Mathen P; Lee J; Camphausen K
Biomark Med; 2019 Feb; 13(3):161-165. PubMed ID: 30806515
[No Abstract] [Full Text] [Related]
4. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
5. Circulating MicroRNAs as Potential Biomarkers in Glioma: A Mini-Review.
Choppavarapu L; Kandi SM
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):195-202. PubMed ID: 32744979
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
Ma C; Nguyen HPT; Luwor RB; Stylli SS; Gogos A; Paradiso L; Kaye AH; Morokoff AP
PLoS One; 2018; 13(2):e0189452. PubMed ID: 29444091
[TBL] [Abstract][Full Text] [Related]
7. A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker.
Santangelo A; Imbrucè P; Gardenghi B; Belli L; Agushi R; Tamanini A; Munari S; Bossi AM; Scambi I; Benati D; Mariotti R; Di Gennaro G; Sbarbati A; Eccher A; Ricciardi GK; Ciceri EM; Sala F; Pinna G; Lippi G; Cabrini G; Dechecchi MC
J Neurooncol; 2018 Jan; 136(1):51-62. PubMed ID: 29076001
[TBL] [Abstract][Full Text] [Related]
8. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
[TBL] [Abstract][Full Text] [Related]
9. Identification of miRNA signatures in serum exosomes as a potential biomarker after radiotherapy treatment in glioma patients.
Li Z; Ye L; Wang L; Quan R; Zhou Y; Li X
Ann Diagn Pathol; 2020 Feb; 44():151436. PubMed ID: 31865249
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA is a biomarker for post-operative monitoring in glioma.
Morokoff A; Jones J; Nguyen H; Ma C; Lasocki A; Gaillard F; Bennett I; Luwor R; Stylli S; Paradiso L; Koldej R; Paldor I; Molania R; Speed TP; Webb A; Infusini G; Li J; Malpas C; Kalincik T; Drummond K; Siegal T; Kaye AH
J Neurooncol; 2020 Sep; 149(3):391-400. PubMed ID: 32915353
[TBL] [Abstract][Full Text] [Related]
11. Plasma miR-454-3p as a potential prognostic indicator in human glioma.
Shao N; Wang L; Xue L; Wang R; Lan Q
Neurol Sci; 2015 Feb; 36(2):309-13. PubMed ID: 25190548
[TBL] [Abstract][Full Text] [Related]
12. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
Wang Q; Li P; Li A; Jiang W; Wang H; Wang J; Xie K
J Exp Clin Cancer Res; 2012 Nov; 31(1):97. PubMed ID: 23174013
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
Zhang YC; Xu Z; Zhang TF; Wang YL
World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
[TBL] [Abstract][Full Text] [Related]
14. Identification and Evaluation of Serum MicroRNA-29 Family for Glioma Screening.
Wu J; Li L; Jiang C
Mol Neurobiol; 2015 Dec; 52(3):1540-1546. PubMed ID: 25367878
[TBL] [Abstract][Full Text] [Related]
15. Circulating biomarkers for gliomas.
Westphal M; Lamszus K
Nat Rev Neurol; 2015 Oct; 11(10):556-66. PubMed ID: 26369507
[TBL] [Abstract][Full Text] [Related]
16. [Circulating microrPas as new potential biomarkers for the diagnosis of high-grade gliomas].
Gareev IF; Novicova LB; Beylerli OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(5):86-90. PubMed ID: 31317895
[TBL] [Abstract][Full Text] [Related]
17. Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
Jin Z; Jin RH; Ma C; Li HS; Xu HY
J BUON; 2017; 22(2):474-480. PubMed ID: 28534372
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as efficient biomarkers in high-grade gliomas.
Barciszewska AM
Folia Neuropathol; 2016; 54(4):369-374. PubMed ID: 28139816
[TBL] [Abstract][Full Text] [Related]
19. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs: potential biomarkers for common malignancies.
Khoury S; Tran N
Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
